Error in a study of the outcome of mantle cell lymphoma: Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur

Authors :: Geisler, Christian H.
Kolstad, Arne
Laurell, Anna
Jerkeman, Mats
Räty, Riikka
Andersen, Niels S.
Pedersen, Lone B.
Eriksson, Mikael
Nordström, Marie
Kimby, Eva
Bentzen, Hans
Kuittinen, Outi
Lauritzsen, Grete F.
Nilsson-Ehle, Herman
Ralfkiær, Elisabeth
Ehinger, Mats
Sundström, Christer
Delabie, Jan
Karjalainen-Lindsberg, Marja-Liisa
Brown, Peter
Source :: British Journal of Haematology. Sep2012, Vol. 158 Issue 6, p815-816. 2p. 1 Chart, 1 Graph.
Publication Year :: 2012
Abstract: A correction to the article "Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: Still very long survival but late relapses do occur" published in previous issue is presented.

Full Text Access

Tools